Portage Biotech (PRTG) announced that on June 24, 2025, the Company received formal notice from The Nasdaq Stock Market that the Company has evidenced compliance with all applicable requirements for continued listing on The Nasdaq Capital Market.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRTG:
- Portage Biotech and Compedica Forge Strategic Alliance with Stock Exchange
- Portage Biotech, Compedica enter mutual subscription agreement
- Portage Biotech Appoints New Auditor Following Marcum Resignation
- Portage Biotech files $40M mixed securities shelf
- Portage Biotech Announces Preclinical Success for PORT-7 in Mesothelioma